Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Research

Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives

Authors: Kathryn E. Weaver, Emily V. Dressler, Sydney Smith, Chandylen L. Nightingale, Heidi D. Klepin, Simon Craddock Lee, Brian J. Wells, W. Gregory Hundley, Joseph A. DeMari, Sarah N. Price, Randi E. Foraker

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Guidelines recommend cardiovascular risk assessment and counseling for cancer survivors. For effective implementation, it is critical to understand survivor cardiovascular health (CVH) profiles and perspectives in community settings. We aimed to (1) Assess survivor CVH profiles, (2) compare self-reported and EHR-based categorization of CVH factors, and (3) describe perceptions regarding addressing CVH during oncology encounters.

Methods

This cross-sectional analysis utilized data from an ongoing NCI Community Oncology Research Program trial of an EHR heart health tool for cancer survivors (WF-1804CD). Survivors presenting for routine care after potentially curative treatment recruited from 8 oncology practices completed a pre-visit survey, including American Heart Association Simple 7 CVH factors (classified as ideal, intermediate, or poor). Medical record abstraction ascertained CVD risk factors and cancer characteristics. Likert-type questions assessed desired discussion during oncology care.

Results

Of 502 enrolled survivors (95.6% female; mean time since diagnosis = 4.2 years), most had breast cancer (79.7%). Many survivors had common cardiovascular comorbidities, including high cholesterol (48.3%), hypertension or high BP (47.8%) obesity (33.1%), and diabetes (20.5%); 30.5% of survivors received high cardiotoxicity potential cancer treatment. Less than half had ideal/non-missing levels for physical activity (48.0%), BMI (18.9%), cholesterol (17.9%), blood pressure (14.1%), healthy diet (11.0%), and glucose/ HbA1c (6.0%). While > 50% of survivors had concordant EHR-self-report categorization for smoking, BMI, and blood pressure; cholesterol, glucose, and A1C were unknown by survivors and/or missing in the EHR for most. Most survivors agreed oncology providers should talk about heart health (78.9%).

Conclusions

Tools to promote CVH discussion can fill gaps in CVH knowledge and are likely to be well-received by survivors in community settings.

Trial registration

NCT03935282, Registered 10/01/2020
Appendix
Available only for authorised users
Literature
1.
go back to reference Shelburne N, Adhikari B, Brell J, Davis M, Desvigne-Nickens P, Freedman A et al. Cancer treatment–related cardiotoxicity: current state of knowledge and future research priorities. J Natl Cancer Inst. 2014;106(9). Shelburne N, Adhikari B, Brell J, Davis M, Desvigne-Nickens P, Freedman A et al. Cancer treatment–related cardiotoxicity: current state of knowledge and future research priorities. J Natl Cancer Inst. 2014;106(9).
2.
go back to reference Lajous M, Mozaffarian D, Mozaffarian R, Schrag D, Adami HO. Lifestyle prescriptions for cancer survivors and their communities. J Intern Med. 2011;269(1):88–93.PubMedCrossRef Lajous M, Mozaffarian D, Mozaffarian R, Schrag D, Adami HO. Lifestyle prescriptions for cancer survivors and their communities. J Intern Med. 2011;269(1):88–93.PubMedCrossRef
3.
go back to reference Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64.PubMedPubMedCentralCrossRef Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64.PubMedPubMedCentralCrossRef
4.
go back to reference van Erning FN, van Steenbergen LN, Lemmens VEPP, Rutten HJT, Martijn H, van Spronsen DJ, et al. Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best? Eur J Cancer. 2014;50(10):1731–9.PubMedCrossRef van Erning FN, van Steenbergen LN, Lemmens VEPP, Rutten HJT, Martijn H, van Spronsen DJ, et al. Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best? Eur J Cancer. 2014;50(10):1731–9.PubMedCrossRef
5.
go back to reference Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 2012;126(2):176–9.PubMedCrossRef Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 2012;126(2):176–9.PubMedCrossRef
6.
go back to reference Stoltzfus KC, Zhang Y, Sturgeon K, Sinoway LI, Trifiletti DM, Chinchilli VM, et al. Fatal heart disease among cancer patients. Nat Commun. 2020;11(1):2011.PubMedPubMedCentralCrossRef Stoltzfus KC, Zhang Y, Sturgeon K, Sinoway LI, Trifiletti DM, Chinchilli VM, et al. Fatal heart disease among cancer patients. Nat Commun. 2020;11(1):2011.PubMedPubMedCentralCrossRef
7.
go back to reference Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889–97.PubMedPubMedCentralCrossRef Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889–97.PubMedPubMedCentralCrossRef
8.
go back to reference Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, et al. Cardiovascular disease risk among cancer survivors: the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol. 2022;80(1):22–32.PubMedPubMedCentralCrossRef Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, et al. Cardiovascular disease risk among cancer survivors: the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol. 2022;80(1):22–32.PubMedPubMedCentralCrossRef
9.
go back to reference Coughlin SS, Datta B, Guha A, Wang X, Weintraub NL. Cardiovascular conditions and obesity among gynecologic cancer survivors: results from the 2020 behavioral risk factor surveillance system survey. Gynecol Oncol. 2022;165(3):405–9.PubMedCrossRef Coughlin SS, Datta B, Guha A, Wang X, Weintraub NL. Cardiovascular conditions and obesity among gynecologic cancer survivors: results from the 2020 behavioral risk factor surveillance system survey. Gynecol Oncol. 2022;165(3):405–9.PubMedCrossRef
10.
go back to reference Underwood J, Townsend J, Stewart S, Buchannan N, Ekwueme D, Hawkins N, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors — behavioral risk factor surveillance system, United States, 2009. MMWR Surveill Summ. 2012;61(1):1–23.PubMed Underwood J, Townsend J, Stewart S, Buchannan N, Ekwueme D, Hawkins N, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors — behavioral risk factor surveillance system, United States, 2009. MMWR Surveill Summ. 2012;61(1):1–23.PubMed
11.
go back to reference Hershman DL, Till C, Shen S, Wright JD, Ramsey SD, Barlow WE, et al. Association of cardiovascular risk factors with cardiac events and survival outcomes among patients with breast cancer enrolled in SWOG clinical trials. J Clin Oncol. 2018;36(26):2710–7.PubMedPubMedCentralCrossRef Hershman DL, Till C, Shen S, Wright JD, Ramsey SD, Barlow WE, et al. Association of cardiovascular risk factors with cardiac events and survival outcomes among patients with breast cancer enrolled in SWOG clinical trials. J Clin Oncol. 2018;36(26):2710–7.PubMedPubMedCentralCrossRef
12.
go back to reference Rubens M, Appunni S, Ramamoorthy V, Saxena A, Das S, Bhatt C, et al. Prevalence of cardiovascular risk factors among cancer patients in the United States. Metab Syndr Relat Disord. 2019;17(8):397–405.PubMedCrossRef Rubens M, Appunni S, Ramamoorthy V, Saxena A, Das S, Bhatt C, et al. Prevalence of cardiovascular risk factors among cancer patients in the United States. Metab Syndr Relat Disord. 2019;17(8):397–405.PubMedCrossRef
13.
go back to reference Foraker RE, Shoben AB, Kelley MM, Lai AM, Lopetegui MA, Jackson RD, et al. Electronic health record-based assessment of cardiovascular health: the stroke prevention in healthcare delivery environments (SPHERE) study. Prev Med Rep. 2016;4:303–8.PubMedPubMedCentralCrossRef Foraker RE, Shoben AB, Kelley MM, Lai AM, Lopetegui MA, Jackson RD, et al. Electronic health record-based assessment of cardiovascular health: the stroke prevention in healthcare delivery environments (SPHERE) study. Prev Med Rep. 2016;4:303–8.PubMedPubMedCentralCrossRef
14.
go back to reference Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD. Community prevalence of ideal cardiovascular health, by the american heart association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57(16):1690–6.PubMedPubMedCentralCrossRef Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD. Community prevalence of ideal cardiovascular health, by the american heart association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57(16):1690–6.PubMedPubMedCentralCrossRef
15.
go back to reference Rasmussen-Torvik LJ, Shay CM, Abramson JG, Friedrich CA, Nettleton JA, Prizment AE, et al. Ideal cardiovascular health is inversely associated with incident cancer: the atherosclerosis risk in communities study. Circulation. 2013;127(12):1270–5.PubMedPubMedCentralCrossRef Rasmussen-Torvik LJ, Shay CM, Abramson JG, Friedrich CA, Nettleton JA, Prizment AE, et al. Ideal cardiovascular health is inversely associated with incident cancer: the atherosclerosis risk in communities study. Circulation. 2013;127(12):1270–5.PubMedPubMedCentralCrossRef
16.
go back to reference Kulshreshtha A, Vaccarino V, Judd SE, Howard VJ, McClellan WM, Muntner P, et al. Life’s simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013;44(7):1909–14.PubMedCrossRef Kulshreshtha A, Vaccarino V, Judd SE, Howard VJ, McClellan WM, Muntner P, et al. Life’s simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013;44(7):1909–14.PubMedCrossRef
17.
go back to reference Hurt RD, Ebbert JO, Hays JT, McFadden DD. Preventing lung cancer by treating tobacco dependence. Clin Chest Med. 2011;32(4):645–57.PubMedCrossRef Hurt RD, Ebbert JO, Hays JT, McFadden DD. Preventing lung cancer by treating tobacco dependence. Clin Chest Med. 2011;32(4):645–57.PubMedCrossRef
18.
go back to reference Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes. Obes Metabolism. 2011;13(12):1063–72.CrossRef Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes. Obes Metabolism. 2011;13(12):1063–72.CrossRef
19.
go back to reference Thomson C, Rock C, Thompson P, Caan B, Cussler E, Flatt S, et al. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the women’s healthy eating and living study. Breast Cancer Res Treat. 2011;125(2):519–27.PubMedCrossRef Thomson C, Rock C, Thompson P, Caan B, Cussler E, Flatt S, et al. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the women’s healthy eating and living study. Breast Cancer Res Treat. 2011;125(2):519–27.PubMedCrossRef
20.
go back to reference Oeffinger KC, Tonorezos ES. The cancer is over. now what? Cancer. 2011;117(S10):2250–7.PubMed Oeffinger KC, Tonorezos ES. The cancer is over. now what? Cancer. 2011;117(S10):2250–7.PubMed
21.
go back to reference Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011;105(S1):52–S73.CrossRef Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011;105(S1):52–S73.CrossRef
22.
go back to reference Lau ES, Paniagua SM, Liu E, Jovani M, Li SX, Takvorian K, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3(1):48–58.PubMedPubMedCentralCrossRef Lau ES, Paniagua SM, Liu E, Jovani M, Li SX, Takvorian K, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3(1):48–58.PubMedPubMedCentralCrossRef
23.
go back to reference Duprez DA, Otvos J, Sanchez OA, Mackey RH, Tracy R, Jacobs DR. Comparison of the predictive value of GlycA and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events. Clin Chem. 2016;62(7):1020–31.PubMedCrossRef Duprez DA, Otvos J, Sanchez OA, Mackey RH, Tracy R, Jacobs DR. Comparison of the predictive value of GlycA and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events. Clin Chem. 2016;62(7):1020–31.PubMedCrossRef
24.
go back to reference Kroenke CH, Chen WY, Rosner B, Holmes MD, Weight. Weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370–8.PubMedCrossRef Kroenke CH, Chen WY, Rosner B, Holmes MD, Weight. Weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370–8.PubMedCrossRef
25.
go back to reference Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, et al. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prevention: Publication Am Association Cancer Res Cosponsored Am Soc Prev Oncol. 2012;21(8):1260–71.CrossRef Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, et al. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prevention: Publication Am Association Cancer Res Cosponsored Am Soc Prev Oncol. 2012;21(8):1260–71.CrossRef
26.
go back to reference Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50(15):1435–41.PubMedCrossRef Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50(15):1435–41.PubMedCrossRef
27.
go back to reference Denlinger CS, Sanft T, Moslehi JJ, Overholser L, Armenian S, Baker KS, et al. NCCN guidelines insights: survivorship, version 2.2020. J Natl Compr Canc Netw. 2020;18(8):1016–23.PubMedPubMedCentralCrossRef Denlinger CS, Sanft T, Moslehi JJ, Overholser L, Armenian S, Baker KS, et al. NCCN guidelines insights: survivorship, version 2.2020. J Natl Compr Canc Netw. 2020;18(8):1016–23.PubMedPubMedCentralCrossRef
28.
go back to reference Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;35(8):893–911.PubMedCrossRef Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;35(8):893–911.PubMedCrossRef
29.
go back to reference Weaver KE, Klepin HD, Wells BJ, Dressler EV, Winkfield KM, Lamar ZS, et al. Cardiovascular assessment tool for breast cancer survivors and oncology providers: usability study. JMIR Cancer. 2021;7(1):e18396.PubMedPubMedCentralCrossRef Weaver KE, Klepin HD, Wells BJ, Dressler EV, Winkfield KM, Lamar ZS, et al. Cardiovascular assessment tool for breast cancer survivors and oncology providers: usability study. JMIR Cancer. 2021;7(1):e18396.PubMedPubMedCentralCrossRef
30.
go back to reference Sacco RL. The new American Heart Association 2020 goal: achieving ideal cardiovascular health. J Cardiovasc Med (Hagerstown). 2011;12(4):255–7.PubMedCrossRef Sacco RL. The new American Heart Association 2020 goal: achieving ideal cardiovascular health. J Cardiovasc Med (Hagerstown). 2011;12(4):255–7.PubMedCrossRef
32.
go back to reference Foraker R, Shoben AB, Lopetegui MA, Lai AM, Payne PR, Kelley M, Roth C, Tindle H, Schreiner A, Jackson RD. Assessment of life’s simple 7 in the primary care setting: the stroke prevention in healthcare delivery EnviRonmEnts (SPHERE) study. Contemp Clin Trials. 2014;38(2):182–9.PubMedCrossRef Foraker R, Shoben AB, Lopetegui MA, Lai AM, Payne PR, Kelley M, Roth C, Tindle H, Schreiner A, Jackson RD. Assessment of life’s simple 7 in the primary care setting: the stroke prevention in healthcare delivery EnviRonmEnts (SPHERE) study. Contemp Clin Trials. 2014;38(2):182–9.PubMedCrossRef
33.
go back to reference Foraker RE, Kite B, Kelley MM, Lai AM, Roth C, Lopetegui MA, et al. EHR-based visualization tool: adoption rates, satisfaction, and patient outcomes. eGEMs. 2015;3(2):1159.PubMedPubMedCentralCrossRef Foraker RE, Kite B, Kelley MM, Lai AM, Roth C, Lopetegui MA, et al. EHR-based visualization tool: adoption rates, satisfaction, and patient outcomes. eGEMs. 2015;3(2):1159.PubMedPubMedCentralCrossRef
34.
go back to reference Foraker RE, Davidson EC, Dressler EV, Wells BJ, Lee SC, Klepin HD, et al. Addressing cancer survivors’ cardiovascular health using the automated heart health assessment (AH-HA) EHR tool: initial protocol and modifications to address COVID-19 challenges. Contemp Clin Trials Commun. 2021;22:100808.PubMedPubMedCentralCrossRef Foraker RE, Davidson EC, Dressler EV, Wells BJ, Lee SC, Klepin HD, et al. Addressing cancer survivors’ cardiovascular health using the automated heart health assessment (AH-HA) EHR tool: initial protocol and modifications to address COVID-19 challenges. Contemp Clin Trials Commun. 2021;22:100808.PubMedPubMedCentralCrossRef
35.
go back to reference Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.PubMedCrossRef Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.PubMedCrossRef
38.
go back to reference Byers T, Patnaik JL. Missed opportunities for chronic disease prevention after breast cancer. Women’s Health. 2011;7(6):619–21.PubMed Byers T, Patnaik JL. Missed opportunities for chronic disease prevention after breast cancer. Women’s Health. 2011;7(6):619–21.PubMed
39.
go back to reference de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561–70.PubMedPubMedCentralCrossRef de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561–70.PubMedPubMedCentralCrossRef
40.
go back to reference Daher I, Daigle T, Bhatia N, Durand J. The prevention of cardiovascular disease in cancer survivors. Tex Heart Inst J. 2012;39(2):190–8.PubMedPubMedCentral Daher I, Daigle T, Bhatia N, Durand J. The prevention of cardiovascular disease in cancer survivors. Tex Heart Inst J. 2012;39(2):190–8.PubMedPubMedCentral
42.
go back to reference Haque R, Prout M, Geider A, Kamineni A, Thwin S, Avila C, et al. Comorbidities and cardiovascular disease risk in older breast cancer survivors. Am J Manag Care. 2014;20(1):86–92.PubMedPubMedCentral Haque R, Prout M, Geider A, Kamineni A, Thwin S, Avila C, et al. Comorbidities and cardiovascular disease risk in older breast cancer survivors. Am J Manag Care. 2014;20(1):86–92.PubMedPubMedCentral
43.
go back to reference Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst. 2019;111(11):1120–30.PubMedPubMedCentralCrossRef Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst. 2019;111(11):1120–30.PubMedPubMedCentralCrossRef
44.
go back to reference Halpern MT, Viswanathan M, Evans TS, Birken SA, Basch E, Mayer DK. Models of cancer survivorship care: overview and summary of current evidence. J Oncol Pract. 2015;11(1):e19–27.PubMedCrossRef Halpern MT, Viswanathan M, Evans TS, Birken SA, Basch E, Mayer DK. Models of cancer survivorship care: overview and summary of current evidence. J Oncol Pract. 2015;11(1):e19–27.PubMedCrossRef
45.
47.
go back to reference Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, et al. Life’s essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18–e43.PubMedPubMedCentralCrossRef Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, et al. Life’s essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18–e43.PubMedPubMedCentralCrossRef
48.
go back to reference Lloyd-Jones DM, Ning H, Labarthe D, Brewer L, Sharma G, Rosamond W, et al. Status of cardiovascular health in US adults and children using the American Heart Association’s new life’s essential 8 metrics: prevalence estimates from the national health and nutrition examination survey (NHANES), 2013 through 2018. Circulation. 2022;146(11):822–35.PubMedCrossRef Lloyd-Jones DM, Ning H, Labarthe D, Brewer L, Sharma G, Rosamond W, et al. Status of cardiovascular health in US adults and children using the American Heart Association’s new life’s essential 8 metrics: prevalence estimates from the national health and nutrition examination survey (NHANES), 2013 through 2018. Circulation. 2022;146(11):822–35.PubMedCrossRef
49.
go back to reference Zhou ES, Partridge AH, Syrjala KL, Michaud AL, Recklitis CJ. Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv. 2017;11(1):74–9.PubMedCrossRef Zhou ES, Partridge AH, Syrjala KL, Michaud AL, Recklitis CJ. Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv. 2017;11(1):74–9.PubMedCrossRef
Metadata
Title
Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives
Authors
Kathryn E. Weaver
Emily V. Dressler
Sydney Smith
Chandylen L. Nightingale
Heidi D. Klepin
Simon Craddock Lee
Brian J. Wells
W. Gregory Hundley
Joseph A. DeMari
Sarah N. Price
Randi E. Foraker
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-11912-8

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine